Institutional investors purchased a net $76.8 thousand shares of JNP during the quarter ended March 2016 and now own 35.79% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MERIT CAPITAL NV Bought 13.8 Thousand shares of Juniper Pharmaceuticals I...